폐활량계 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of spirometer Market

The global spirometer market size was valued at USD 679.85 million in 2025. The market is projected to grow from USD 716.61 million in 2026 to USD 1,122.92 million by 2034, exhibiting a CAGR of 6.63% during the forecast period (2026-2034).

North America dominated the spirometer market with a 50.46% market share in 2025, supported by high respiratory disease prevalence and strong healthcare infrastructure.

A spirometer is a diagnostic medical device used to measure lung function by assessing the volume of air inhaled and exhaled. It plays a crucial role in diagnosing and managing respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. According to the Forum of International Respiratory Societies (2023), around 334 million people suffer from asthma globally, and more than 65 million people are affected by COPD, highlighting the growing demand for spirometry devices.

Although the COVID-19 pandemic negatively impacted the market due to temporary closures of pulmonary function testing (PFT) labs, recovery began in 2021-2022 with the reopening of healthcare facilities and rising demand for respiratory diagnostics.

SPIROMETER MARKET TRENDS

Growing Investment in Smart and Connected Devices

Rising investments in digital health and connected spirometry solutions are driving market growth. Companies are developing Bluetooth-enabled and AI-integrated spirometers for remote monitoring.

For instance, in January 2023, Aluna secured USD 15.3 million in Series B funding to expand its app-connected spirometry solution for asthma, COPD, and cystic fibrosis management. Similarly, partnerships such as Clario and ArtiQ (March 2023) are enhancing AI-driven spirometry data analysis in clinical trials.

The adoption of smart spirometers has shown a reduction in emergency visits and hospitalizations related to asthma, further strengthening product demand.

MARKET GROWTH FACTORS

Increasing Technological Advancements

Technological innovation is a key growth driver. Portable, handheld, and user-friendly spirometry devices have addressed underutilization challenges. In January 2020, NuvoAir's connected spirometer received FDA approval in the U.S., enabling remote lung monitoring.

Artificial intelligence integration is further improving diagnostic accuracy and treatment optimization. Continuous R&D investments are expected to support early COPD detection and improve disease management outcomes.

Rising Prevalence of COPD

COPD is the third leading cause of death worldwide. According to the National Heart, Lung, and Blood Institute (2022), approximately 16 million Americans suffer from COPD. Smoking, pollution, and environmental exposures are major contributors. The growing global burden of respiratory diseases is significantly boosting demand for spirometry testing.

RESTRAINING FACTORS

Shortage of Skilled Professionals

A major limitation is the shortage of trained pulmonary function technologists. According to WHO (2023), there could be a shortfall of 10 million healthcare workers by 2030, particularly in low-income countries. Limited skilled workforce and lack of awareness in developing regions may restrict device adoption.

SEGMENTATION ANALYSIS

By Product Type

The market is segmented into devices, software, and accessories & consumables.

• The devices segment dominated with a 52.75% share, driven by increasing demand for advanced diagnostic equipment.
• The software segment is expected to grow significantly due to digital health adoption.
• Accessories & consumables maintain steady demand due to reusable device components.

By Type

The market includes volume measurement spirometers and peak flow meters.

• The volume measurement segment held 47.71% share in 2026, owing to accurate results and wide clinical applications.
• Peak flow meters are growing due to increasing availability of wireless and portable solutions.

By Application

Segments include COPD, asthma, and others.

• The COPD segment accounted for 45.38% share in 2026, driven by increasing disease prevalence.
• Asthma remains a major contributor, especially among children.

By End User

The market is segmented into hospitals, diagnostic centers, homecare settings, clinics, and others.

• The hospitals segment is projected to hold 35.34% share in 2026, supported by rising healthcare expenditure.
• Homecare settings are witnessing rapid growth due to patient preference for remote monitoring solutions.

REGIONAL INSIGHTS

North America

North America recorded a market size of USD 343.07 million in 2025 and held a dominant 50.46% share. High COPD and asthma prevalence, strong regulatory support, and presence of major players drive regional growth. The U.S. market is projected to reach USD 324.53 million in 2026.

Europe

Europe is projected to grow steadily due to increasing awareness and regulatory approvals. The UK market is projected to reach USD 37.73 million in 2026, while Germany is expected to reach USD 24.12 million in 2026.

Asia Pacific

Asia Pacific is anticipated to witness strong growth due to increasing investments and product launches. The Japan market is projected to reach USD 19.4 million in 2026, China USD 26.85 million, and India USD 25.08 million.

Rest of the World

Latin America and the Middle East & Africa hold comparatively smaller shares but are improving through training programs and awareness campaigns.

COMPETITIVE LANDSCAPE

Key companies include ndd Medizintechnik AG, COSMED srl, MGC Diagnostics, Morgan Scientific, VYAIRE, Ganshorn, and MIR. Strategic collaborations, acquisitions, and AI integration initiatives are strengthening competitive positioning. For example, CAIRE Inc. acquired MGC Diagnostics in January 2023 to expand its respiratory diagnostics portfolio.

CONCLUSION

The global spirometer market is set to grow steadily from USD 679.85 million in 2025 to USD 716.61 million in 2026, reaching USD 1,122.92 million by 2034 at a CAGR of 6.63%. Growth is primarily driven by the increasing prevalence of COPD and asthma, technological advancements in portable and AI-enabled spirometry devices, and expanding home healthcare adoption.

North America remains the leading region with a 50.46% share in 2025, while Asia Pacific is emerging as a high-growth market. Although workforce shortages and limited awareness in developing countries pose challenges, rising investments, regulatory support, and digital health integration are expected to unlock long-term opportunities.

Segmentation By Product Type

• Devices
• Software
• Accessories & Consumables

By Type

• Volume Measurement
• Peak Flow Meters

By Application

• Chronic Obstructive Pulmonary Disorder (COPD)
• Asthma
• Others

By End User

• Hospitals
• Diagnostic Centers
• Homecare Settings
• Physician/Primary Care Offices or Clinics
• Other Facilities

By Region

• North America (By Product Type, By Type, By Application, By End-User, By Country)
  • U.S. (By Type)
  • Canada (By Type)
• Europe (By Product Type, By Type, By Application, By End-User, By Country/Sub-Region)
  • U.K. (By Type)
  • Germany (By Type)
  • France (By Type)
  • Italy (By Type)
  • Spain (By Type)
  • Scandinavia (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
  • Japan (By Type)
  • China (By Type)
  • India (By Type)
  • Australia (By Type)
  • Southeast Asia (By Type)
  • Rest of the Asia Pacific (By Type)
• Latin America (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
  • GCC (By Type)
  • South Africa (By Type)
  • Rest of the Middle East & Africa (By Type)

Table of Content

1. Introduction

• 1.1. Market Scope
• 1.2. Market Segmentation
• 1.3. Market Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Respiratory Disorders, By Key Countries/Regions, 2025
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.4. Regulatory Scenario, By Key Countries/Regions
• 4.5. Technological Advancements Pertaining to Spirometer
• 4.6. Telespirometry - Qualitative and Quantitative Insights
• 4.7. Impact of COVID-19 on the Market

5. Global Spirometer Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Devices
  • 5.1.2. Software
  • 5.1.3. Accessories & Consumables
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Volume Measurement
  • 5.2.2. Peak Flow Meters
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
  • 5.3.2. Asthma
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Diagnostic Centers
  • 5.4.3. Homecare Settings
  • 5.4.4. Physician/Primary Care Offices or Clinics
  • 5.4.5. Other Facilities
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Spirometer Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Devices
  • 6.1.2. Software
  • 6.1.3. Accessories & Consumables
• 6.2. Market Analysis, Insights and Forecast - By Type
  • 6.2.1. Volume Measurement
  • 6.2.2. Peak Flow Meters
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
  • 6.3.2. Asthma
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Diagnostic Centers
  • 6.4.3. Homecare Settings
  • 6.4.4. Physician/Primary Care Offices or Clinics
  • 6.4.5. Other Facilities
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Type
  • 6.5.2. Canada
    • 6.5.2.1. By Type

7. Europe Spirometer Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Devices
  • 7.1.2. Software
  • 7.1.3. Accessories & Consumables
• 7.2. Market Analysis, Insights and Forecast - By Type
  • 7.2.1. Volume Measurement
  • 7.2.2. Peak Flow Meters
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
  • 7.3.2. Asthma
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Diagnostic Centers
  • 7.4.3. Homecare Settings
  • 7.4.4. Physician/Primary Care Offices or Clinics
  • 7.4.5. Other Facilities
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Type
  • 7.5.2. Germany
    • 7.5.2.1. By Type
  • 7.5.3. France
    • 7.5.3.1. By Type
  • 7.5.4. Italy
    • 7.5.4.1. By Type
  • 7.5.5. Spain
    • 7.5.5.1. By Type
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Type
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Type

8. Asia Pacific Spirometer Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Devices
  • 8.1.2. Software
  • 8.1.3. Accessories & Consumables
• 8.2. Market Analysis, Insights and Forecast - By Type
  • 8.2.1. Volume Measurement
  • 8.2.2. Peak Flow Meters
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
  • 8.3.2. Asthma
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Diagnostic Centers
  • 8.4.3. Homecare Settings
  • 8.4.4. Physician/Primary Care Offices or Clinics
  • 8.4.5. Other Facilities
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Type
  • 8.5.2. China
    • 8.5.2.1. By Type
  • 8.5.3. India
    • 8.5.3.1. By Type
  • 8.5.4. Australia
    • 8.5.4.1. By Type
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Type
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Type

9. Latin America Spirometer Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Devices
  • 9.1.2. Software
  • 9.1.3. Accessories & Consumables
• 9.2. Market Analysis, Insights and Forecast - By Type
  • 9.2.1. Volume Measurement
  • 9.2.2. Peak Flow Meters
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
  • 9.3.2. Asthma
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Diagnostic Centers
  • 9.4.3. Homecare Settings
  • 9.4.4. Physician/Primary Care Offices or Clinics
  • 9.4.5. Other Facilities
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Type
  • 9.5.2. Mexico
    • 9.5.2.1. By Type
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Type

10. Middle East & Africa Spirometer Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Devices
  • 10.1.2. Software
  • 10.1.3. Accessories & Consumables
• 10.2. Market Analysis, Insights and Forecast - By Type
  • 10.2.1. Volume Measurement
  • 10.2.2. Peak Flow Meters
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
  • 10.3.2. Asthma
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Diagnostic Centers
  • 10.4.3. Homecare Settings
  • 10.4.4. Physician/Primary Care Offices or Clinics
  • 10.4.5. Other Facilities
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
    • 10.5.1.1. By Type
  • 10.5.2. South Africa
    • 10.5.2.1. By Type
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. ndd Medizintechnik AG
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. COSMED srl
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. MGC Diagnostics Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Morgan Scientific
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Chest M.I., Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. VYAIRE
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Ganshorn Medizin Electronic GmbH
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Medical International Research (MIR)
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)